Phase II trial of evobrutinib in multiple sclerosis
- PMID: 31127249
- DOI: 10.1038/s41582-019-0212-2
Phase II trial of evobrutinib in multiple sclerosis
Comment on
-
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.N Engl J Med. 2019 Jun 20;380(25):2406-2417. doi: 10.1056/NEJMoa1901981. Epub 2019 May 10. N Engl J Med. 2019. PMID: 31075187 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources